Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 16:22 (476 d 09:45 ago) – Posting: # 20812
Views: 3,332

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

 Admin contact
21,371 posts in 4,463 threads, 1,495 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Sunday 02:07 UTC (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz